4/26
11:17 am
axgn
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million [Globe and Mail, The (Toronto, Canada)]
Low
Report
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million [Globe and Mail, The (Toronto, Canada)]
4/26
11:12 am
axgn
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million [Yahoo! Finance]
Low
Report
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million [Yahoo! Finance]
4/24
10:00 am
axgn
AxoGen (AXGN) was given a new $45.00 price target by Canaccord Genuity Group Inc..
Medium
Report
AxoGen (AXGN) was given a new $45.00 price target by Canaccord Genuity Group Inc..
4/23
08:47 pm
axgn
Is It Too Late To Consider Axogen (AXGN) After Its 1-Year Share Price Surge? [Yahoo! Finance]
Medium
Report
Is It Too Late To Consider Axogen (AXGN) After Its 1-Year Share Price Surge? [Yahoo! Finance]
4/23
03:22 pm
axgn
AxoGen (AXGN) had its price target raised by Lake Street Capital from $40.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
AxoGen (AXGN) had its price target raised by Lake Street Capital from $40.00 to $50.00. They now have a "buy" rating on the stock.
4/22
03:40 pm
axgn
Axogen (AXGN) Q2 2025 Earnings Transcript [Yahoo! Finance]
Neutral
Report
Axogen (AXGN) Q2 2025 Earnings Transcript [Yahoo! Finance]
4/14
07:00 am
axgn
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
Low
Report
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
4/2
09:57 am
axgn
What Makes Axogen (AXGN) an Investment Bet? [Yahoo! Finance]
Medium
Report
What Makes Axogen (AXGN) an Investment Bet? [Yahoo! Finance]
3/30
11:54 am
axgn
AxoGen (AXGN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $40.00 price target on the stock.
Low
Report
AxoGen (AXGN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $40.00 price target on the stock.
3/24
03:30 pm
axgn
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know [Yahoo! Finance]
Low
Report
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know [Yahoo! Finance]
3/21
08:23 pm
axgn
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth [Yahoo! Finance]
Medium
Report
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth [Yahoo! Finance]
3/12
11:02 am
axgn
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum [Yahoo! Finance]
Low
Report
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum [Yahoo! Finance]
3/5
09:32 pm
axgn
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]
Low
Report
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]
2/26
06:33 am
axgn
AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/25
03:37 pm
axgn
A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]
Low
Report
A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]
2/24
03:42 pm
axgn
Axogen (AXGN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Axogen (AXGN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/24
11:51 am
axgn
Axogen targets at least 18% revenue growth in 2026 as BLA milestone strengthens market position [Seeking Alpha]
Low
Report
Axogen targets at least 18% revenue growth in 2026 as BLA milestone strengthens market position [Seeking Alpha]
2/24
10:56 am
axgn
AxoGen Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
AxoGen Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
09:41 am
axgn
AxoGen (NASDAQ:AXGN) had its price target raised by analysts at Citizens Jmp from $34.00 to $42.00. They now have a "market outperform" rating on the stock.
Low
Report
AxoGen (NASDAQ:AXGN) had its price target raised by analysts at Citizens Jmp from $34.00 to $42.00. They now have a "market outperform" rating on the stock.
2/24
07:42 am
axgn
AxoGen: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
AxoGen: Q4 Earnings Snapshot [Yahoo! Finance]
2/24
07:25 am
axgn
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
2/24
07:00 am
axgn
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
Low
Report
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
2/24
06:03 am
axgn
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
High
Report
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
2/23
10:57 am
axgn
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
2/20
07:27 am
axgn
AxoGen (NASDAQ:AXGN) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Medium
Report
AxoGen (NASDAQ:AXGN) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.